QuidelOrtho Corporation (QDEL)

Market Cap	1.87B
Revenue (ttm)	2.71B
Net Income (ttm)	-1.18B
Shares Out	67.93M
EPS (ttm)	-17.44
PE Ratio	n/a
Forward PE	12.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,404,024
Open	27.68
Previous Close	28.14
Day's Range	27.48 - 28.32
52-Week Range	19.50 - 49.45
Beta	0.59
Analysts	Hold
Price Target	39.33 (+43.02%)
Earnings Date	Nov 5, 2025

About QDEL

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 6,600
• Stock Exchange: NASDAQ
• Ticker Symbol: QDEL
• Website: https://www.quidelortho.com

Financial Performance

In 2024, QuidelOrtho's revenue was $2.78 billion, a decrease of -7.17% compared to the previous year's $3.00 billion. Losses were -$2.05 billion, 20216.8% more than in 2023.

Analyst Summary

According to 6 analysts, the average rating for QDEL stock is "Hold." The 12-month stock price target is $39.33, which is an increase of 43.02% from the latest price.

Price Target

$39.33

(43.02% upside)

Analyst Consensus: Hold